Aims: Although clinical trials have demonstrated superior clinical efficacy and improved safety of the everolimus-eluting stent (EES) compared with paclitaxel-eluting ste
1. The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, Ohio, USA; 2. Maasstad Ziekenhuis, Rotterdam, The Netherlands; 3. New York-Presbyterian Hospital, Columbia University Medical Center and the Cardiovascular Research
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
drug eluting stentsclinical outcomescoronary artery diseasemultivessel